[1] R KIKKAWA. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.[J]. Diabetologia, 1983, 24 4: 290-292. DOI:
10.1007/bf00282716[2] H TERASHIMA. Effects of a new aldose reductase inhibitor on various tissues in vitro.[J]. Journal of Pharmacology and Experimental Therapeutics, 1984, 229 1: 226-230.
[3] MARY ANN RAMIREZ Nancy L B. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.[J]. Pharmacotherapy, 2008, 28 5: 646-655. DOI:
10.1592/phco.28.5.646